CBUS
Price
$1.26
Change
-$0.07 (-5.26%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
67.25M
HXBM
Price
$4.50
Change
+$0.50 (+12.50%)
Updated
Aug 18 closing price
Capitalization
1.01M
Interact to see
Advertisement

CBUS vs HXBM

Header iconCBUS vs HXBM Comparison
Open Charts CBUS vs HXBMBanner chart's image
Cibus
Price$1.26
Change-$0.07 (-5.26%)
Volume$3.34K
Capitalization67.25M
Helix BioMedix
Price$4.50
Change+$0.50 (+12.50%)
Volume$400
Capitalization1.01M
CBUS vs HXBM Comparison Chart in %
Loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HXBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBUS vs. HXBM commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a Hold and HXBM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CBUS: $1.33 vs. HXBM: $4.50)
Brand notoriety: CBUS and HXBM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 30% vs. HXBM: 189%
Market capitalization -- CBUS: $67.25M vs. HXBM: $1.01M
CBUS [@Biotechnology] is valued at $67.25M. HXBM’s [@Biotechnology] market capitalization is $1.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 1 FA rating(s) are green whileHXBM’s FA Score has 1 green FA rating(s).

  • CBUS’s FA Score: 1 green, 4 red.
  • HXBM’s FA Score: 1 green, 4 red.
According to our system of comparison, both CBUS and HXBM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 4 TA indicator(s) are bullish while HXBM’s TA Score has 3 bullish TA indicator(s).

  • CBUS’s TA Score: 4 bullish, 3 bearish.
  • HXBM’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, CBUS is a better buy in the short-term than HXBM.

Price Growth

CBUS (@Biotechnology) experienced а -2.21% price change this week, while HXBM (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CBUS($67.3M) has a higher market cap than HXBM($1.01M). HXBM YTD gains are higher at: -43.750 vs. CBUS (-52.158).
CBUSHXBMCBUS / HXBM
Capitalization67.3M1.01M6,657%
EBITDA-262.49MN/A-
Gain YTD-52.158-43.750119%
P/E RatioN/AN/A-
Revenue4.85MN/A-
Total Cash36.5MN/A-
Total Debt35.4MN/A-
FUNDAMENTALS RATINGS
CBUS vs HXBM: Fundamental Ratings
CBUS
HXBM
OUTLOOK RATING
1..100
5418
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9494
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HXBM's Valuation (5) in the null industry is in the same range as CBUS (16). This means that HXBM’s stock grew similarly to CBUS’s over the last 12 months.

HXBM's Profit vs Risk Rating (100) in the null industry is in the same range as CBUS (100). This means that HXBM’s stock grew similarly to CBUS’s over the last 12 months.

HXBM's SMR Rating (99) in the null industry is in the same range as CBUS (99). This means that HXBM’s stock grew similarly to CBUS’s over the last 12 months.

HXBM's Price Growth Rating (94) in the null industry is in the same range as CBUS (94). This means that HXBM’s stock grew similarly to CBUS’s over the last 12 months.

HXBM's P/E Growth Rating (100) in the null industry is in the same range as CBUS (100). This means that HXBM’s stock grew similarly to CBUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBUSHXBM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
33%
Momentum
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 2 days ago
8%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
9%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
8%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
29%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
20%
View a ticker or compare two or three
Interact to see
Advertisement
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HXBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSLOY16.160.20
+1.25%
Mitsui O.S.K. Lines Ltd.
LCNTU460.25N/A
N/A
Louisiana Central Oil & Gas Co.
DRRSF0.11N/A
-2.14%
Arianne Phosphate Inc
KPLUY6.59-0.19
-2.80%
K + S AG
TAKOF0.39-0.02
-4.88%
VOLATUS AEROSPACE INC.

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with CGEM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
-0.75%
CGEM - CBUS
36%
Loosely correlated
-0.66%
CRBU - CBUS
36%
Loosely correlated
+0.53%
ARCT - CBUS
36%
Loosely correlated
-1.82%
ABOS - CBUS
35%
Loosely correlated
N/A
RXRX - CBUS
34%
Loosely correlated
-0.85%
More

HXBM and

Correlation & Price change

A.I.dvisor indicates that over the last year, HXBM has been loosely correlated with GLMD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HXBM jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HXBM
1D Price
Change %
HXBM100%
N/A
GLMD - HXBM
38%
Loosely correlated
N/A
CBUS - HXBM
26%
Poorly correlated
-0.75%
NCNA - HXBM
25%
Poorly correlated
-6.58%
APVO - HXBM
22%
Poorly correlated
-2.44%
INRLF - HXBM
2%
Poorly correlated
N/A
More